文献速递肾小球疾病

免疫触须样肾小球病:单克隆与多克隆变异型的罕见实体

Immunotactoid glomerulopathy is a rare entity with monoclonal and polyclonal variants.
PubMed 文献 · Kidney Int · 2020-08-18

该研究描述了73例免疫触须样肾小球病(ITG)患者的临床、病理及结局特征,常见表现为蛋白尿、血尿和肾功能不全。66%患者存在血液系统疾病,免疫荧光显示67%病例为单克隆IgG沉积,据此分为单克隆和多克隆变异型。单克隆ITG更常接受克隆导向治疗,与更高的缓解率和更低的终末期肾病发生率相关。

要点

  • 所有ITG患者均应进行血液系统评估,因66%合并血液病。
  • 免疫荧光IgG限制性提示单克隆ITG,需区分单克隆与多克隆变异型。
  • 单克隆ITG接受克隆导向治疗可改善缓解率并减少终末期肾病。

核心结论

  • ITG应分为单克隆和多克隆变异型,单克隆型更常合并淋巴瘤等血液病且克隆导向治疗预后良好。

研究设计与样本

  • 回顾性描述73例ITG患者的临床、病理和结局特征。

主要发现

  • 66%患者有血液系统疾病,包括淋巴瘤41%、单克隆丙种球蛋白病20%、多发性骨髓瘤6%。
  • 光镜显示内皮细胞增生型35%、膜增生型29%、膜型29%。
  • 电镜见14-60 nm微管状沉积物,空心,常平行排列,主要分布于肾小球基底膜致密层外侧。
  • 免疫荧光67%病例为IgG限制性(轻链和IgG亚类限制),提示单克隆组成。
  • 单克隆ITG较之多克隆型,淋巴瘤发生率53% vs. 11%,多发性骨髓瘤8% vs. 0,单克隆丙种球蛋白病22% vs. 16%。

关键数值与推荐

  • 单克隆ITG更常接受克隆导向治疗,与更频繁缓解和更少终末期肾病相关。

临床怎么用

  • 对所有ITG患者进行血液系统评估,依据免疫荧光分型指导克隆导向治疗。

局限性

  • 原文未报告研究设计的具体局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Immunotactoid glomerulopathy (ITG) is a rare form of glomerulonephritis for which our understanding is limited to case reports and small case series. Herein we describe the clinical, pathologic, and outcome characteristics of 73 patients with ITG who typically presented with proteinuria, hematuria, and renal insufficiency. Hematologic disorders were present in 66% of patients, including lymphoma in 41% (mainly chronic lymphocytic leukemia/small lymphocytic lymphoma), monoclonal gammopathy in 20%, and multiple myeloma in 6%. Light microscopy revealed endocapillary proliferative (35%), membranoproliferative (29%) and membranous (29%) patterns of glomerular involvement. Electron microscopy revealed characteristic microtubular deposits with a diameter of 14-60 nm, hollow cores, frequent parallel alignment, and a predominant distribution outside of the lamina densa of the glomerular basement membrane. Importantly, immunofluorescence revealed IgG-dominant staining which was light chain and IgG subclass restricted in 67% of cases, indicating monoclonal composition. This finding was used to distinguish monoclonal and polyclonal variants of ITG. As compared to polyclonal, monoclonal ITG had a higher incidence of lymphoma (53% vs. 11%), multiple myeloma (8% vs. 0), and monoclonal gammopathy (22% vs. 16%). Monoclonal ITG was more commonly treated with clone-directed therapy, which was associated with more frequent remission and less frequent end stage kidney disease. Thus, a third of ITG cases are polyclonal but a quarter of these cases are associated with hematologic conditions, underscoring the need for hematologic evaluation in all patients with ITG. Hence, based on these distinctions, ITG should be subclassified into monoclonal and polyclonal variants. Prognosis of ITG is good if the underlying hematologic condition is treated.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Nasr SH, Kudose SS, Said SM, et al. Immunotactoid glomerulopathy is a rare entity with monoclonal and polyclonal variants. Kidney Int. 2020. PMID: 32818517. doi:10.1016/j.kint.2020.07.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。